Novanta Reports Q3 Results Exceeding Expectations Amidst Major Acquisition
Novanta (NASDAQ: NOVT) reported third-quarter financial results that surpassed analyst expectations across key metrics, including revenue, adjusted EBITDA, and adjusted EPS. The company characterized the quarter as a milestone period, highlighted by the successful closing of its largest acquisition to date, Riverpoint Medical. Despite facing temporary operational disruptions at its Stockport facility, management provided an optimistic long-term outlook. Novanta is targeting more than 15% reported growth through 2027, signaling confidence in its strategic expansion and integration of new assets.
Tickers: $NOVT
Topics: acquisition earnings beat EBITDA EPS revenue growth
Read the full article at Seeking Alpha
Part of the story Oddity Tech Reports Q3 2026 Results Exceeding Guidance Amid Advertising Challenges (4 articles)